Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial

por D'Urzo, Anthony, Ferguson, Gary T, van Noord, Jan A, Hirata, Kazuto, Martin, Carmen, Horton, Rachael, Lu, Yimeng, Banerji, Donald, Overend, Tim
Publicado 2011

Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease

por van den Berge, Maarten, Hop, Wim CJ, van der Molen, Thys, van Noord, Jan A, Creemers, Jacques PHM, Schreurs, Ad JM, Wouters, Emiel FM, Postma, Dirkje S
Publicado 2012